Also trades as: ABBOTINDIA.NS (NSE) · $vol 3M
ABBOTINDIA.BO BSE
Abbott India Limited
1W: -0.3%
1M: +2.4%
3M: +3.8%
YTD: -1.8%
1Y: -18.7%
3Y: +15.7%
5Y: +57.6%
₹26,780.00 ($278.09)
-369.40 (-1.36%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#1
of 10
Drug Manufacturers - General
Technical Signal Map
6 Bullish
0 Neutral
5 Bearish
ABBOTINDIA.BO
$570B
Abbott India Limited
BULLISH
+53
SMSPHARMA.NS
$44B
SMS Pharmaceuticals Limited
BULLISH
+100
KOPRAN.NS
$14B
Kopran Limited
BULLISH
+82
ABBOTINDIA.NS
$571B
Abbott India Limited
BULLISH
+78
NGLFINE.NS
$18B
NGL Fine-Chem Limited
BULLISH
+68
MARKSANS.NS
$148B
Marksans Pharma Limited
LEAN BULL
+24
GLAXO.NS
$469B
GlaxoSmithKline Pharmaceuticals Limited
BEARISH
-34
SENORES.NS
$62B
Senores Pharmaceuticals Ltd.
BEARISH
-75
TTKHLTCARE.NS
$14B
TTK Healthcare Limited
BEARISH
-75
PFIZER.NS
$177B
Pfizer Limited
BEARISH
-91
SANOFICONR.NS
$87B
Sanofi Consumer Healthcare India Ltd.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| ABBOTINDIA.BO Abbott India Limited | $570B | 35.3 | 34.5 | 50.4 | 23.1 | 8.1 | 6 | BULLISH | -18.7 |
| SMSPHARMA.NS SMS Pharmaceuticals Limited | $44B | 41.9 | 14.3 | 9.3 | 13.7 | 13.3 | 7 | BULLISH | 101.9 |
| KOPRAN.NS Kopran Limited | $14B | 54.7 | 4.9 | 6.7 | 8.1 | 8.2 | 5 | BULLISH | 81.7 |
| ABBOTINDIA.NS Abbott India Limited | $571B | 35.3 | 34.5 | 50.4 | 23.1 | 8.1 | 6 | BULLISH | -18.5 |
| NGLFINE.NS NGL Fine-Chem Limited | $18B | 31.3 | 15.7 | 10.1 | 9.0 | 36.1 | 4 | BULLISH | 121.2 |
| MARKSANS.NS Marksans Pharma Limited | $148B | 28.3 | 15.2 | 15.8 | 17.3 | 12.5 | 6 | LEAN BULL | 82.3 |
| GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited | $469B | 43.8 | 49.1 | -201.0 | 27.9 | 2.6 | 5 | BEARISH | -0.1 |
| SENORES.NS Senores Pharmaceuticals Ltd. | $62B | — | — | — | — | — | — | BEARISH | 99.9 |
| TTKHLTCARE.NS TTK Healthcare Limited | $14B | 19.3 | 6.0 | 6.8 | 10.0 | 7.0 | 4 | BEARISH | -10.4 |
| PFIZER.NS Pfizer Limited | $177B | 24.0 | 17.2 | 59.2 | 31.8 | 10.4 | 6 | BEARISH | -32.3 |
| SANOFICONR.NS Sanofi Consumer Healthcare India Ltd. | $87B | 32.7 | 17.3 | 189.0 | 26.5 | — | 4 | BEARISH | -28.3 |
| ABBOTINDIA.BO Abbott India Limited | $570B | 35.3 | 34.5 | 50.4 | 23.1 | 8.1 | 6 | BULLISH | -18.7 |
| SMSPHARMA.NS SMS Pharmaceuticals Limited | $44B | 41.9 | 14.3 | 9.3 | 13.7 | 13.3 | 7 | BULLISH | 101.9 |
| KOPRAN.NS Kopran Limited | $14B | 54.7 | 4.9 | 6.7 | 8.1 | 8.2 | 5 | BULLISH | 81.7 |
| ABBOTINDIA.NS Abbott India Limited | $571B | 35.3 | 34.5 | 50.4 | 23.1 | 8.1 | 6 | BULLISH | -18.5 |
| NGLFINE.NS NGL Fine-Chem Limited | $18B | 31.3 | 15.7 | 10.1 | 9.0 | 36.1 | 4 | BULLISH | 121.2 |
| MARKSANS.NS Marksans Pharma Limited | $148B | 28.3 | 15.2 | 15.8 | 17.3 | 12.5 | 6 | LEAN BULL | 82.3 |
| GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited | $469B | 43.8 | 49.1 | -201.0 | 27.9 | 2.6 | 5 | BEARISH | -0.1 |
| SENORES.NS Senores Pharmaceuticals Ltd. | $62B | — | — | — | — | — | — | BEARISH | 99.9 |
| TTKHLTCARE.NS TTK Healthcare Limited | $14B | 19.3 | 6.0 | 6.8 | 10.0 | 7.0 | 4 | BEARISH | -10.4 |
| PFIZER.NS Pfizer Limited | $177B | 24.0 | 17.2 | 59.2 | 31.8 | 10.4 | 6 | BEARISH | -32.3 |
| SANOFICONR.NS Sanofi Consumer Healthcare India Ltd. | $87B | 32.7 | 17.3 | 189.0 | 26.5 | — | 4 | BEARISH | -28.3 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
ABBOTINDIA.BO vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F